Theseus

  • Study Sponsor and Protocol Number: 
    Sanofi Theseus
  • Specialty:
    Pulmonary
  • Type:
    Investigational Drug
  • Inclusion:
    Age 40 - 80
    Diagnosis of COPD
  • Exclusion:
    Pulmonary diseases besides COPD